| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli)
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA2
|
annexin A2
|
|
API5
|
apoptosis inhibitor 5
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BFAR
|
bifunctional apoptosis regulator
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C3
|
complement component 3
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCNE2
|
cyclin E2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD1D
|
CD1d molecule
|
|
CD34
|
CD34 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDA
|
cytidine deaminase
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHKA
|
choline kinase alpha
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLU
|
clusterin
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
CRYGD
|
crystallin, gamma D
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DHFR
|
dihydrofolate reductase
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DNAJC3
|
DnaJ (Hsp40) homolog, subfamily C, member 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DRD2
|
dopamine receptor D2
|
|
DSG2
|
desmoglein 2
|
|
DVL1P1
|
dishevelled segment polarity protein 1 pseudogene 1
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV4
|
ets variant 4
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGG
|
fibrinogen gamma chain
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FTO
|
fat mass and obesity associated
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
|
GH1
|
growth hormone 1
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HDAC3
|
histone deacetylase 3
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLF
|
hepatic leukemia factor
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXC11
|
homeobox C11
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IL13
|
interleukin 13
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IMPACT
|
impact RWD domain protein
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIF2C
|
kinesin family member 2C
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT8
|
keratin 8, type II
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIMK2
|
LIM domain kinase 2
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT4A
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A
|
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR130B
|
microRNA 130b
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR195
|
microRNA 195
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR23B
|
microRNA 23b
|
|
MIR27B
|
microRNA 27b
|
|
MIR495
|
microRNA 495
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOD1
|
myogenic differentiation 1
|
|
NANOG
|
Nanog homeobox
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NEK11
|
NIMA-related kinase 11
|
|
NEK6
|
NIMA-related kinase 6
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NINL
|
ninein-like
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLG
|
plasminogen
|
|
PLIN1
|
perilipin 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRSS3
|
protease, serine, 3
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMD7
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
REST
|
RE1-silencing transcription factor
|
|
RETN
|
resistin
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RPL6
|
ribosomal protein L6
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SKI
|
SKI proto-oncogene
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC25A31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD7
|
SMAD family member 7
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRI
|
sorcin
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STK11
|
serine/threonine kinase 11
|
|
STXBP3
|
syntaxin binding protein 3
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYK
|
spleen tyrosine kinase
|
|
TCF3
|
transcription factor 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TERC
|
telomerase RNA component
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLR4
|
toll-like receptor 4
|
|
TMPRSS15
|
transmembrane protease, serine 15
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM5
|
tripartite motif containing 5
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VRK1
|
vaccinia related kinase 1
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZNF43
|
zinc finger protein 43
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
